Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harish Seethapathy

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
JAMA Network Open|July 5, 2023
Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With CancerPaul E Hanna, Qiyu Wang, Ian A Strohbehn, et al.
NEJM Evidence|February 6, 2024
Severe Hyponatremia Correction, Mortality, and Central Pontine MyelinolysisHarish Seethapathy, Sophia Zhao, Tianqi Ouyang, et al.
Plos One|May 24, 2019
Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placementAndrew S Allegretti, Nathan E Frenk, Darrick K Li, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2019
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint InhibitorsHarish Seethapathy, Sophia Zhao, Donald F Chute, et al.
Cancer Letters|July 30, 2025
Comparative safety of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in patients receiving anti-neoplastic therapies for cancer: An inverse probability treatment weighting analysisJiaxuan Lyu, Katherine Specht, Jacqueline A Seiglie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2020
Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell LymphomaShruti Gupta, Harish Seethapathy, Ian A Strohbehn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 26, 2021
Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint InhibitorsDonald F Chute, Sophia Zhao, Ian A Strohbehn, et al.
Kidney International Reports|December 18, 2023
Pyelonephritis is an Underrecognized Cause of CKD in Patients With Orthotopic Ileal Neobladder SubstitutionQiyu Wang, Rituvanthikaa Seethapathy, Tianqi Ouyang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 23, 2020
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinibHarish Seethapathy, Meghan D Lee, Ian A Strohbehn, et al.
Kidney International Reports|October 26, 2020
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 InhibitorsHarish Seethapathy, Sophia Zhao, Ian A Strohbehn, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
JAMA Network Open|July 5, 2023
Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With CancerPaul E Hanna, Qiyu Wang, Ian A Strohbehn, et al.
NEJM Evidence|February 6, 2024
Severe Hyponatremia Correction, Mortality, and Central Pontine MyelinolysisHarish Seethapathy, Sophia Zhao, Tianqi Ouyang, et al.
Plos One|May 24, 2019
Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placementAndrew S Allegretti, Nathan E Frenk, Darrick K Li, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2019
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint InhibitorsHarish Seethapathy, Sophia Zhao, Donald F Chute, et al.
Cancer Letters|July 30, 2025
Comparative safety of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in patients receiving anti-neoplastic therapies for cancer: An inverse probability treatment weighting analysisJiaxuan Lyu, Katherine Specht, Jacqueline A Seiglie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2020
Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell LymphomaShruti Gupta, Harish Seethapathy, Ian A Strohbehn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 26, 2021
Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint InhibitorsDonald F Chute, Sophia Zhao, Ian A Strohbehn, et al.
Kidney International Reports|December 18, 2023
Pyelonephritis is an Underrecognized Cause of CKD in Patients With Orthotopic Ileal Neobladder SubstitutionQiyu Wang, Rituvanthikaa Seethapathy, Tianqi Ouyang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 23, 2020
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinibHarish Seethapathy, Meghan D Lee, Ian A Strohbehn, et al.
Kidney International Reports|October 26, 2020
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 InhibitorsHarish Seethapathy, Sophia Zhao, Ian A Strohbehn, et al.
Pageof 6